U.S.A.). Trypsin was supplied from Kawayam (Japan). Extraction and Fractionation The dried plant material (4.0 kg) was extracted three times with MeOH under reflux for 5 h and the filtered extract was evaporated on a rotatory evaporator under reduced pressure to give a viscous MeOH extract (460 g). This was suspended in H 2 O and then partitioned with CHCl 3 , EtOAc, and n-BuOH, successively, to give a CHCl 3 -soluble fraction (84 g), an EtOAc-soluble fraction (48 g), and a n-BuOH-soluble fraction (118 g).
Alkaline Hydrolysis of EtOAc-and BuOH Fraction To obtain the aglycones from EtOAc-and BuOH-soluble fraction containing triterpenoid glycosides, the two fractions were hydrolyzed in alkaline conditions. BuOH fraction (20 g) was refluxed in 3%-NaOH (MeOH-H 2 O, 2 : 8, 300 ml) solution for 5 h. After cooling, the reaction mixture was acidified with d-HCl and then extracted with EtOAc (each 300 ml). The EtOAc layer was washed with 150 ml distilled water two times and then the EtOAc layer was concentrated (8 g) . Alkaline hydrolysis of the EtOAc fraction (10 g) was also carried out by the same way with the case of the BuOH fraction to hydrolize the esterified sugar linkage and resultantly afforded an alkaline hydrolysate (4 g).
Isolation of Niga-ichigoside F 1 and 23-Hydroxytormentic Acid Twenty grams of each BuOH or EtOAc extracts were chromatographed over silica gel (700 g, 8ϫ52 cm, Merck, Art 7734, Germany) with the eluting solvent of CHCl 3 -MeOH-H 2 O (7 : 3 : 1, lower phase). Eluents were collected with at 80 ml each and checked with 10% H 2 SO 4 . Comound 1 (Rf 0.31) was shown at the retention volume over 1.40-2.90 l. The eluents containing compound 1 was dried in vacuo. Compound 1 was identified as niga-ichigoside F 1
As an attempt to search for bioactive natural constituents exerting antinociceptive and antiinflammatory activities, we examined the potency of the extract of Rubus coreanus fruits by the activity-guided fractionation. The EtOAc-and BuOH fraction and those alkaline hydrolysates showed significant antinociceptive effects as assessed by writhing-, hot plate-and tail flicks tests in mice and rats as well as antiinflammatory effect in rats with carrageenan-induced edema. BuOH extract was subjected to column chromatography to obtain a large amount of niga-ichigoside F 1 (1,23-hydroxytormentic acid 28-O-glc), which was again hydrolyzed in NaOH solution to yield an aglycone 23-hydroxytormentic acid (1a). The aglycone, 23-hydroxytormentic acid, was much more potent in both antinociceptive and antiinflammatory tests than the glycoside, niga-ichigoside F 1 . The antiinflammatory effects of these compounds were further supported by the reduction of carrageenan-induced lipid peroxidation and hydroxyl radical in serum. These results suggested that 23-hydroxytormentic acid might be an active moiety of niga-ichigoside F 1 present in R. coreanus.
on the basis of physical and spectroscopic data:
ϩ11.2°(cϭ1.01, MeOH), 1 H-NMR (C 5 D 5 N, 500 MHz) and 13 C-NMR (C 5 D 5 N, 125 MHz) were identical with those reported in the literature. 10) Compound 1a was obtained by the hydrolysis of BuOH fraction. BuOH fraction was heated in 5%-NaOH solution for 5 h under reflux. After cooling, the reaction mixture was acidified with d-HCl and extracted three times with each 300 ml EtOAc and then washed two times with 150 ml distilled water. EtOAc fraction obtained was dried and then recrystalyzed in MeOH to give white needles (1a D 20 ϩ27.9°(cϭ0.54, MeOH), 1 H-NMR (C 5 D 5 N, 500 MHz) and 13 C-NMR (C 5 D 5 N, 125 MHz) were identical with those reported in the literature. 10) Animals Both 4 week-old ICR male mice and Sprague-Dawley male rats were purchased from Dae Han Bio Link Co. and adapted them in a constant condition (temperature: 20Ϯ2°C, dampness: 40-60%, light/dark cycle: 12 h) for two weeks or more. Twenty-four hours before the experiment, only water was offered to the animals. Considering the variation of enzyme activity during one day, the animals were sacrificed at fixed time (10:00 a.m.-12:00 a.m.).
Writhing Test in Mice The acetic acid abdominal constriction test was performed as described by Whittle. 11) Vehicle, aspirin (100 mg/kg) and test solution (each fraction: 100, 200 mg/kg, compounds 1, 1a: 10, 30 mg/kg) were orally administered 30 min before the experiment, and 0.1 ml/10 g of 0.7% acetic acid-saline was then injected i.p. 10 min after the injection, the frequency of writhing in mice was counted for the succeeding 10 min.
Hot Plate Test The hot plate test was used to measure the response latencies according to the method described previously by Eddy and Leimback, 12) with minor modifications. In these experiments, the hot plate (Ugo Basile, model-DS 37) was maintained at 56Ϯ1°C. The reaction time was noted by observing either the licking of the hind paws or the jumping movements before and after drug administration. The cut-off time was 20 s and morphine sulphate 10.0 mg/kg (Kuju Pharmaceutical CO), administered intraperitoneally, was used as reference drug. 13) Tail-Flicks Test The antinoceptive responses were determined by measuring the time required to respond to a radiating thermal stimulus. The rat was restrained so that the radiant heat source was focused onto the base of the tail. An au-tomatized tail-flick analgesymeter (Ugo Basile Italy) was used, and the cut-off time was set at 15 s. For each rat, three determinations were carried out before material administration (control latency). The tail-flick latency responses are expressed as a percentage of analgesia calculated. The intensity of the thermal stimulus was adjusted to obtain control latency between 4 and 6 s (Tail-flicks method). 14) Carrageenan-Induced Edema in Rats The initial hind paw volume of the Sprague-Dawley strain rats was determined volumetrically. A 1% solution of carrageenan in saline (0.1 ml/rat) was injected subcutaneously into the right hind paw 1 h after the test substances had been administered orally. Test samples including the extracts and the isolated components were, first, dissolved with 10% tween 80 and diluted by saline. The same volume of solvent only was administered for the normal group. The test solution (each fraction: 100, 200 mg/kg, compounds 1, 1a: 10, 30 mg/kg) had been orally administered for 7 d before the injection of carrageenan. The control group received the vehicle. Paw volumes were measured up to 5 h at intervals of 60 min, and the volume of the edema was measured with a plethysmometer. 14) Ibuprofen, an anti-inflammatory drug, was used as a standard drug. 15) Acetic Acid-Induced Vascular Permeability in Mice The method is based on that of Whittle. 11) The mice were dosed orally with the test substances suspended in 0.2% carboxymethyl cellulose (CMC) solution 30 min before the injection of acetic acid-saline solutions. Thirty minutes after the injection (i.p., 0.7% acetic acid-saline 0.1 ml/10 g), 4% pontamine sky blue (10 ml/kg) was also injected to tail vein. After 20 min, the mice were sacrificed and then the pigment exuded to abdominal cavity was washed with 10 ml of distilled water. This washed solution was centrifuged (3000 rpm, 10 min) and then the absorbance of supernatants was measured at 580 nm wavelength using UV-VIS spectrophotometer. The vascular permeability effects were expressed in terms of dye amount per 30 g weight of mouse, which leaked into the intraperitoneal cavity. Aspirin was used as a standard drug. 16) Measurement of Trypsin Activity The trypsin inhibitor activity was measured according to Bieth et al. 17) and Fritz et al. method. 18) The absorbance of N-benzoylarginine-p-nitroanilide (BAPNA) was measured at 405 nm indicating that the conversion of BAPNA to N-benzoylarginine and p-nitroaniline by trypsin activity. In brief, trypsin solution (50 mU/ml) and triethanolamine buffer solution (0.2 M triethanolamine, 20 mM CaCl 2 , pH 7.8) were added to the test tubes containing inhibitor assay (I) and trypsin reference assay (Tr), respectively and preincubated at 37°C for 5 min. Then, the substrate of BAPNA was added and its reaction rate was determined every 1 min for 5 min by the absorbances taken at 405 nm by UV-VIS spectrophotometer. The unit of enzyme activity was expressed as IU/ml. Inhibitor unit (IU) was determined by the following formula: inhibitor activity (IU)ϭ(DA Tr /minϪDA I /min)/3.32, where A represents the absorbance. The unit of enzyme activity was expressed as IU/ml.
Measurement of Lipid Peroxide, Hydroxy Radical and Superoxide Dismutase (SOD) Activity in Serum 1) Lipid
Peroxide in Serum: This content was measured according to the method of Yagi et al. 19) After preincubating serum with 1/12 N H 2 SO 4 and 10% phosphotungsic acid for 5 min, it was centrifuged and the protein pellet obtained was resuspended in 1/12 N H 2 SO 4 and 10% phosphotungstic acid and again the procedure repeated. The protein pellet was then resuspended in 1 ml distilled water, 0.67% thiobarbituric acid and 50% acetic acid at 95°C for 50 min, 5 ml of n-BuOH was added and the whole allowed to stand at room temperature. The red n-BuOH layer obtained centrifuging for 10 min was analyzed by measuring the absorbance using spectrophotometer (Ex: 515 nm, Em 553 nm). Malondialdehyde (MDA; unit, nmol/ml of serum) was obtained from a standard curve.
2) Hydroxy Radical: This was measured according to the method of Tateishi et al. 20) Briefly, 333.3 ml of solution composed of 34.8 ml serum, 0.54 M NaCl, 0.1 M potassium phosphate buffer (pH 7.4), 10 mM NaN 3 , 7 mM deoxyrebose, 5 mM ferrous ammonium sulfate and distilled water was vortexed and stood at 37°C for 15 min. Sixty seven microliters of this mixture was added to a solution of 75 ml of 8.1%-sodium dodecyl sulfate, 67 ml of 20% acetic acid, and distilled water and then 222 ml of 1.2% thiobarbituric acid was added to this solution. The final solution was boiled for 30 min and cooled to room temperature before being centrifuged at 700ϫg for 5 min. The absorbance of the supernatant was determined at 532 nm using a spectrophotometer and concentration of hydroxy radical (unit: nmol/mg protein) present was calculated from a standard curve.
3) SOD Activity: This was determined using the method of Oyanagui et al. 21) Serum was 100-fold diluted with potassium phosphate buffer and 100 ml of the diluted solution was poured into a test tube and again the solutions of 200 ml of A (3 mM hydroxylamine/3 mM hypoxanthine) and 200 ml of B (7.5 mU/ml xanthine oxidase with 0.1 mM EDTA-2Na) and 500 ml distilled water added to the test tube was vortexed and then stood in 37°C water for 40 min. Two milliliters of solution C (300 mg of sulfanilic acid/5.0 mg N-1-naphtyl-ethylenediamine in 500 ml of 16.7% acetic acid) was then added to the final solution and the mix allowed to stand at room temperature for 20 min. The absorbance of the test solution was measured at 550 nm and the SOD activity in serum was calculated from a standard curve.
Statistics All data are expressed as meanϮS.E.M. The level of statistical significance was determined by analysis of variance followed by Duncan's new multiple range test.
RESULTS AND DISCUSSION
Since many saponins such as 19a-hydroxyursane-type triterpenoids and their glycosides have been isolated from the Rubus sp. plants, 2) we first prepared MeOH fraction of the fruits of R. coreanus. The antinoceptive effect was assessed by three different models: the acetic acid-induced writhingtest, hot plate test and tail-flicks tests in mice and rats, whereas the antiinflammatory effects were examined using rats with carrageenan-induced edema. This extract exhibited antinociceptive and antiinflammatory effects ( Tables 1, 2) and was further fractionated into CHCl 3 -, EtOAc-and BuOH extract for the activity-guided fractionation, and the EtOAc and BuOH extracts were hydrolyzed under alkaline condition, respectively. We previously found that the hydrolyzed compounds from the triterpenoid glycosides show significant bioactivities. 22, 23) The potency of the fractions after 100 and 200 mg/kg oral administration was shown as follows: EtOAc extractϾBuOH extractϾCHCl 3 extract. Furthermore, silica gel column chromatography of BuOH extract gave a main component nigaichigoside F 1 , which was identified by physical and spectroscopic data. 10) Furthermore, alkaline hydrolysis of nigaichigoside F 1 produced an aglycone 23-hydroxytormentic acid. 10) Niga-ichigoside F 1 and 23-hydroxytormentic acid significantly reduced the number of writhing and stretching induced by the 0.7% acetic acid solution. The percentage of protection by niga-ichigoside F 1 and 23-hydroxytormentic acid ranged from 17.7-24.4 and 32.2-51.6%, respectively. Acetylsalicylic acid (100 mg/kg) also exerted a significant protective effect, inducing a protection of 69.4% (Table 3) . Although this test is a non-specific model (e.g. anticholinergic and antihistaminic and other agents show activity in this test), it is widely used for analgesic screening and involves local peritoneal receptors (cholinergic and histamine receptor) and the mediators of acetylcholine and histamine. The results of hot plate method in mice in Table 3 shows that niga-ichigoside F 1 and 23-hydroxytormentic acid signifi- cantly increased the latency to jumping response at 10 and 30 mg/kg treatment without affecting the animals' ability to detect pain threshold (licking response) of a thermal origin. Morphine (10 mg/kg) also exerted a significant effect in this response. In tail-flick test, morphine is used to induce analgesia. At 1-5 min, when morphine displaced maximum analgesia, 24) significant analgesia was monitored with the niga-ichigoside F 1 and 23-hydroxytormentic acid in a dose of 10 and 30 mg/kg, suggesting that these samples have central analgesic properties. The antinociceptive activity shown by niga-ichigoside F 1 and 23-hydroxytormentic acid in various models indicate that these compounds might possess centrally and peripherally mediated antinociceptive properties. The two compounds (1, 1a) were significantly active in the tests although the aglycone 23-hydroxytormentic acid was much more potent than the glycoside niga-ichigoside F 1 . These results suggest that the aglycone could be an active moiety of the glycoside but the glycoside could be also effective by oral administration. The activities of the two components were comparable with those reference compounds, aspirin and morphine.
As shown in Fig. 2 , anti-inflammatory activities of nigaichigoside F 1 and 23-hydroxytormentic acid were observed 1 h after the carrageenan injection. Maximal edema inhibition was observed at 3 h after the edema induction. In particular, treatment with 23-hydroxytormentic acid (30 mg/kg, p.o.) reduced the edema by 41% at 3 h, and ibuprofen (100 mg/kg, p.o.) treatment decreased the edema rate by 62%. The significance was maintained at least for more than 4 h after the edema induction.
Total dye amount which leaked into the peritoneal cavity was 99.3Ϯ6.17 mg/30 g body weight in the vehicle control group. 23-Hydroxytormentic acid (10, 30 mg/kg, p.o.) significantly reduced the dye leakage as shown in Table 4 , whereas niga-ichgoside was only significantly effective at a dose of 30 mg/kg. A standard drug, aspirin (100 mg/kg, p.o.), also strongly reduced the leakage. As shown in Table 4 , the control value for carrageenan-induced trypsin activity was 0.367Ϯ0.026 IU/ml. Treatment with either 23-hydroxytoementic acid, niga-ichgoside (10, 30 mg/kg, p.o.) or ibuprofen (100 mg/kg, p.o.) significantly suppressed trypsin activity. The results shown in Table 4 suggested that the antiinflammatory effect of the two components was caused by the inhibitory effect on the vascular permeability responsible for the inflammation.
The local and systemic inflammatory response is also associated with the production of ROS such as superoxide anions, hydrogen peroxide and peroxynitrite. 25) In a number of pathophysiological conditions associated with inflammation or oxidant stress, these ROS have been proposed to mediate cell damage via a number of independent mechanisms including (i) the initiation of lipid peroxidation, (ii) the inactivation of a variety of enzymes and (iii) depletion of glutathione. 26) In order to better understand the mechanisms of the observed anti-inflammatory effects of niga-ichigoside F 1 and 23-hydroxytormentic acid, we have also investigated whether these compounds attenuates the levels of lipid peroxide, hydroxy radical and SOD activity caused by carrageenan. Rats treated with carrageenan exhibited a substantial increase in levels of lipid peroxide, hydroxy radical and SOD activity in the serum. Pre-treatments of rats with nigaichigoside F 1 , 23-hydroxytormentic acid and ibuprofen (a reference drug) ( Table 5 ) attenuated the increase in the levels of lipid peroxide, hydroxy radical and SOD activity caused by carrageenan in the serum. All these finding support the finding that niga-ichigoside F 1 and 23-hydroxytormentic acid attenuates the degree of inflammation caused by carrageenan in the rat via antioxidative mechanisms. Our experimental results led to the finding of antinociceptive and antiinflammaotry constituent niga-ichigoside F 1 and the active moiety 23-hydroxytormentic acid. The biologically active triterpenoids usually have 28-carboxyl in those molecules. Our results suggested that the triterpenoid 28-O-glycoside might be active by oral administration though it may have the possibility to be hydrolyzed in gastrointestinal tract or other biosystems. It was also found that the hydrolysate, 23-hydroxytormentic acid, is more active than the parent molecule. 
